Literature DB >> 3145797

Effect of gallium on bone mineral properties.

M A Repo1, R S Bockman, F Betts, A L Boskey, N W Alcock, R P Warrell.   

Abstract

Gallium nitrate is biologically active in blocking bone resorption in vitro as well as in vivo. Administration of gallium nitrate to growing rats results in a dose-dependent accumulation of low levels of gallium in bone that is associated with specific changes in the mineral properties of bone. To elucidate in greater detail the changes induced by gallium, the properties of whole and density-fractionated bone samples from control and gallium-treated rats were examined. These studies showed that short-term treatment with gallium nitrate caused an increase in bone calcium and phosphate content. Devitalized bone powder from the gallium-treated rats was less soluble in acetate buffer and less readily resorbed by monocytes. Density fractionation analyses demonstrated that the largest proportion (76% by weight) of powdered metaphyseal bone particles from rats had a density of less than 2.15 g/cc. Following short-term treatment (14 days) with gallium nitrate (45 mg/kg body weight), a significant increase in the relative proportion of more dense bone (greater than or equal to 2.15 g/cc) was observed (24% for the control vs. 39% for the gallium-treated rats, P less than 0.01). In the diaphyseal samples, the largest proportion (88% by weight) of the bone powder had a density of greater than or equal to 2.15 g/cc. After short-term treatment with gallium, a slight decrease in mean diaphyseal particle density was observed. Measurement of calcium accretion with 45Ca in the gallium-treated rats demonstrated increased specific activity in the metaphyseal bone samples, densities = 2.0, 2.1, 2.15, and 2.25 g/cc; the difference was significant only for the 2.25 g/cc fraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145797     DOI: 10.1007/bf02556640

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  11 in total

1.  Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.

Authors:  R P Warrell; M Issacs; N W Alcock; R S Bockman
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

2.  [Incorporation in vivo of Ca45 by osseous fractions of different density].

Authors:  R Lemaire; L J Richelle
Journal:  Arch Int Physiol Biochim       Date:  1964-03

3.  Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia.

Authors:  R P Warrell; R S Bockman; C J Coonley; M Isaacs; H Staszewski
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

4.  Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.

Authors:  R P Warrell; A Skelos; N W Alcock; R S Bockman
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

5.  Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases.

Authors:  R P Warrell; N W Alcock; R S Bockman
Journal:  J Clin Oncol       Date:  1987-02       Impact factor: 44.544

6.  Mineral and matrix alterations in the bones of incisors-absent (ia/ia) osteopetrotic rats.

Authors:  A L Boskey; S C Marks
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

7.  Pharmacokinetics of gallium nitrate in man.

Authors:  D P Kelsen; N Alcock; S Yeh; J Brown; C Young
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

8.  Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium.

Authors:  M M Hart; R H Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

9.  Mineral parameters in early fracture repair.

Authors:  J M Lane; F Betts; A S Posner; D W Yue
Journal:  J Bone Joint Surg Am       Date:  1984-10       Impact factor: 5.284

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  9 in total

1.  The effect of gallium on seeded hydroxyapatite growth.

Authors:  R Donnelly; A Boskey
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

Review 2.  Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.

Authors:  P A Todd; A Fitton
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy.

Authors:  R S Bockman; M A Repo; R P Warrell; J G Pounds; G Schidlovsky; B M Gordon; K W Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 4.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

5.  Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies.

Authors:  C L Webb; F J Schoen; W E Flowers; A C Alfrey; C Horton; R J Levy
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

6.  A comparison of the physical and chemical differences between cancellous and cortical bovine bone mineral at two ages.

Authors:  Liisa T Kuhn; Marc D Grynpas; Christian C Rey; Yaotang Wu; Jerome L Ackerman; Melvin J Glimcher
Journal:  Calcif Tissue Int       Date:  2008-08-07       Impact factor: 4.333

Review 7.  Gallium containing bioactive materials: A review of anticancer, antibacterial, and osteogenic properties.

Authors:  Fatih Kurtuldu; Nurshen Mutlu; Aldo R Boccaccini; Dušan Galusek
Journal:  Bioact Mater       Date:  2022-01-10

8.  Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro.

Authors:  Jingwu Li; Guang-Bin Wang; Xue Feng; Jing Zhang; Qin Fu
Journal:  Mol Med Rep       Date:  2015-11-19       Impact factor: 2.952

9.  The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in ovariectomized rats.

Authors:  Da-wei Zhang; Zhen-lin Wang; Wei Qi; Guang-yue Zhao
Journal:  BMC Complement Altern Med       Date:  2014-12-13       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.